Aripiprazole Improved Post-Streptococcal Dyskinesia by Modulating Dopaminergic Activity: A Case Report

This case report aimed to discuss the efficacy of aripiprazole for dyskinesia in patients with functional movement disorder after streptococcal infection, with its biological action of modulating dopamine hyperactivity in the basal ganglia as a dopamine partial agonist. This report has shown that th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryou, Jae Hyun, Han, Doug Hyun, Lee, Reeree, Kim, Sun Mi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329106/
https://www.ncbi.nlm.nih.gov/pubmed/35879044
http://dx.doi.org/10.9758/cpn.2022.20.3.581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329106/
https://www.ncbi.nlm.nih.gov/pubmed/35879044
http://dx.doi.org/10.9758/cpn.2022.20.3.581

Ejemplares similares